Key result
Higher BMI polygenic score linked to greater eating disorder severity in anorexia nervosa.
Why the study?
About 20% of individuals with anorexia nervosa remain chronically ill, making early identification of poor outcome essential to improve care.
Does polygenic liability for BMI, anorexia nervosa, or schizophrenia predict eating disorder severity and long-term outcome in patients with anorexia nervosa?
Cohort (n=2,843)
Yes
Does polygenic liability for BMI, anorexia nervosa, or schizophrenia predict eating disorder severity and long-term outcome in patients with anorexia nervosa?
Polygenic scores for BMI, but not for anorexia nervosa or schizophrenia, showed a positive association with eating disorder severity, providing early evidence for the potential clinical utility of polygenic scores in eating disorders.
This is the authors' abstract. We don't add key points for this paper.
About 20% of individuals with anorexia nervosa (AN) remain chronically ill. Therefore, early identification of poor outcome could improve care. Genetic research has identified regions of the genome associated with AN. Patients with anorexia nervosa were identified via the Swedish eating disorder quality registers Stepwise and Riksät and invited to participate in the Anorexia Nervosa Genetics Initiative. First, we associated genetic information longitudinally with eating disorder severity indexed by scores on the Clinical Impairment Assessment (CIA) in 2843 patients with lifetime AN with or without diagnostic migration to other forms of eating disorders followed for up to 16 years (mean = 5.3 years). Second, we indexed the development of a severe and enduring eating disorder (SEED) by a high CIA score plus a follow-up time ≥5 years. We associated individual polygenic scores (PGSs) indexing polygenic liability for AN, schizophrenia, and body mass index (BMI) with severity and SEED. After multiple testing correction, only the BMI PGS when calculated with traditional clumping and p value thresholding was robustly associated with disorder severity ( β PGS = 1.30; 95% CI: 0.72, 1.88; p = 1.2 × 10 –5 ) across all p value thresholds at which we generated the PGS. However, using the alternative PGS calculation method PRS-CS yielded inconsistent results for all PGS. The positive association stands in contrast to the negative genetic correlation between BMI and AN. Larger discovery GWASs to calculate PGS will increase power, and it is essential to increase sample sizes of the AN GWASs to generate clinically meaningful PGS as adjunct risk prediction variables. Nevertheless, this study provides the first evidence of potential clinical utility of PGSs for eating disorders.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for BMI polygenic scores in anorexia nervosa severity; leaves open clinical utility pending prospective validation.
No takes yet. Share an insight, caveat, or question.
Johansson et al. (2022) conducted a cohort in Anorexia nervosa (n=2,843). Body mass index polygenic score (BMI PGS) was evaluated on Eating disorder severity indexed by scores on the Clinical Impairment Assessment (CIA) (β 1.30, 95% CI 0.72, 1.88, p=1.2 × 10–5). A higher body mass index polygenic score was robustly associated with greater eating disorder severity in patients with anorexia nervosa.
Synapse has enriched 10 related papers. Consider them for comparative context: